Mykutis

ABOUT MYKUTIS

Mykutis is a medicated scaffold functionalized with POLYLACTIC ACID* and HYPEROIL, a vegetal based product made of neem and hypericum.

Polylactic acid is a thermoplastic material that is biodegradable and biocompatible in contact with living tissues.
Therefore it is suitable for different kinds of biomedical applications.

Myktutis is classified as a MEDICAL DEVICE - class IIB.

Mykutis is obtained by ELECTROSPINNING and “MESH” TECHNOLOGY.

TECHNOLOGY

ELECTROSPINNING

It is an effective technology for the production of non-woven fabrics made of continuous fibers with well-defined sub-micrometric dimensions.

Fabrics have morphological characteristics and controlled shape, thickness, and surface properties. They are able to mimic the morphology of the fibrous protein component of the extracellular matrix.

MESH TECHNOLOGY

It is a technology that allows you to puncture the scaffold and obtain remarkable expandability in order to facilitate the passage of the exudate.

APPLICATION FIELDS

Plastic Surgery

To cover dermal-epidermal acute lesions, for the management of acute wounds

Wounds Treatment

To treat well-cleansed chronic ulcers, sparsely granulated

ADVANTAGES

  • NO HOSPITALIZATION NEEDED (operating room/outpatient clinic)
  • REDUCES THE NEED FOR RECONSTRUCTIVE SURGICAL PROCEDURE
  • REDUCES THE NEED FOR DRESSING CHANGE UNTIL COMPLETE HEALING
  • BACTERIOSTATIC EFFECT, NO NEED FOR ANTISEPTIC DRESSING
  • MAY BE APPLIED ON EXPOSED BONES AND TENDONS
  • SINOUS APPLICATION, FISTULAS AND/OR TUNNELS
  • EASY APPLICATION thanks to its ELECTROSTATIC PROPERTY
  • FAST TISSUE REGENERATION

HOW TO USE MYKUTIS

Opening Instructions

Open the sterile envelope

CAUTION! Separate and extract MYKUTIS from the 2 meshed medical paper sheets.

STEP 1

Cleanse the floor and perilesional edges of the lesion using the physiological solution (or applying 2-3 drops of Hyperoil® oily formulation, well-distributed with sterile gauze).

STEP 2

Apply MYKUTIS® in single fold, overpassing borders by 2-3 cm, on the floor of ulcers or  lesions granulated and re-epithelialized.

DRESSING CHANGE: within 30 days from its application.

CLINICAL CASES

Clinical Case 1

CASE: 81 YO woman, affected by a traumatic ulcer on the left leg pretibial region.

Recorded data at the first examination: systemic blood pressure 110/60 mmHg, ankle blood pressure 150 mmHg, Ankle Brachial Index (ABI) >1, blood sugar 140mg/dl, hemoglobin (Hb) 9.3 g/dl.

Lesion: Falanga D2 (existing nonvital tissue with moderate exudate), size 69 cm2 (9.8x9.4).

Falanga A1 (existing granulating tissue with moderate exudate), size 18cm2 (6.2 x 4.3).

Falanga A1 (existing granulating tissue with moderate exudate), size 6.4 cm2.

A new application of MYKUTIS.

Complete lesion recovery.

urtare-engcaso-clinico-1-mykutis

Click on the image to reveal the content

Clinical Case 2

CASO: 46 YO woman, affected by a peri-malleolar ulcer on medial right.

Moderate chronic venous insufficiency, histologic diagnosis of pyoderma gangrenosum.

The lesion showed a Falanga A2 of size 5.6 cm2.

MYKUTIS has been applied together with a compressive dressing.  (15-21 mmHg).

Falanga A1 (existing granulating tissue with moderate exudate), size 3 cm2.

A new application of MYKUTIS.

Falanga A1 (existing granulating tissue with moderate exudate), size 0.8 cm2.

urtare-engCaso-Clinico-2-mykutis

Click on the image to reveal the content

Example video of Mykutis application in a clinical case.

ATTENTION: it contains images that may impact your sensitivity.

PACKAGING

MYKUTIS® is packed in a box of no.5 aluminum foil pouches.

Each pouch stores 2 sheets MYKUTIS® scaffold.
Each scaffold  MYKUTIS® is sterile and packed in a sealed medical protective paper.

Available also in a single pouch, it contains 1 scaffold.

MYKUTIS is protected by 2 meshed medical paper sheets.

DESCRIPTIONDATA
Size of single scaffold10 x 7 cm
SterilizazionEO
Expiration4 years

 

PROSEGUI / CONTINUE